340B Litigation After Genesis: Q&A Webinar - McDermott Will & Emery

340B Litigation After Genesis: Q&A Webinar


Join our experienced 340B team for an audience-led, open forum Q&A session to address the long-awaited Genesis HealthCare, Inc. v. Becerra decision. While the Genesis case is broadly viewed as a win for 340B-eligible providers, many questions remain, including:

  • How could the court’s opinion apply to entities other than Genesis?
  • How might 340B-eligible providers expand their 340B programs while remaining in compliance?
  • What does the court’s opinion mean about the Health Resources and Services Administration’s authority to interpret and enforce the 340B statute?

Earlier this month, a federal court in South Carolina issued a long-awaited decision in the case of Genesis HealthCare, Inc. v. Becerra. In its decision, the court stated that a 340B-eligible provider can obtain 340B drugs to fill a prescription from another provider, as long as the individual receiving the drugs is also a patient of the 340B-eligible provider.


November 28, 2023
1:00 – 2:00 pm EST


Dig Deeper

Miami, FL / McDermott Event / March 6-7, 2024

HPE Miami 2024

New York, NY / McDermott Event / November 16, 2023

Healthcare Investment Insights: Navigating Recent Developments

Webinar / McDermott Webinar / November 28, 2023

340B Litigation After Genesis: Q&A Webinar

Indianapolis, IN / NAPABA / November 9-12, 2023

2023 NAPABA Convention

Get In Touch